Spain’s SpliceBio Defies Sentiment With €50m Financing
Gene Therapy Player Backed By UCB And Novartis
The Barcelona-based firm, which has a protein splicing platform that aims to address the major limitation of delivering large genes using AAV vectors, has sealed the largest series A fundraising by a Spanish biotech.
